And the doctor who prescribed it would refute the lack of data, saying the absence of evidence is not evidence of absence, and that his patients are deriving substantial benefit without side effects
Four proline residues, including an unusual triple-proline sequence, confer resistance to enzymatic degradation
For GLP-1 medications like semaglutide or tirzepatide, legitimate examples of a documented clinical difference might include: A patients allergy to an excipient (e.g., phenol or sodium chloride) in the commercial formulation
A total of 26 articles were identified as of October 8, 2024
For further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, see Lilly's Form 10-K and Form 10-Q filings with the Trademarks and Trade Names All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners
